Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses

PURPOSE: Oral metronidazole therapy is the standard of care for bacterial vaginosis (BV), yet it has alarming rates of recurrence and refractory responses among recurrent BV (RBV) patients. This study addresses whether high dose vaginal metronidazole therapy (HDM) is beneficial in RBV patients who f...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Infect Drug Resist
Päätekijät: Sobel, Jack D, Kaur, Navkiranjot, Woznicki, Nicole A, Boikov, Dina, Aguin, Tina, Gill, Gurveer, Akins, Robert A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6661983/
https://ncbi.nlm.nih.gov/pubmed/31413606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S213853
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia